These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 60643)
1. Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa. Lipper S Lancet; 1976 Sep; 2(7985):571-2. PubMed ID: 60643 [No Abstract] [Full Text] [Related]
2. The effects of combining carbidopa with levodopa for Parkinson's disease. Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406 [No Abstract] [Full Text] [Related]
3. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism. Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850 [TBL] [Abstract][Full Text] [Related]
4. Psychiatric symptoms with initiation of carbidopa-levodopa treatment. Lin JT; Ziegler DK Neurology; 1976 Jul; 26(7):699-700. PubMed ID: 945518 [TBL] [Abstract][Full Text] [Related]
5. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340 [TBL] [Abstract][Full Text] [Related]
6. [Effects and side effects to levodopa in parkinsonism- results of a collaborative study. (5) Combined therapy with a peripheral decarboxylase inhibitor]. Omoto T Rinsho Shinkeigaku; 1976 Dec; 16(12):879-80. PubMed ID: 1035531 [No Abstract] [Full Text] [Related]
7. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa. Gawel M; Riopelle R; Libman I; Bouchard S Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263 [No Abstract] [Full Text] [Related]
8. The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years. Hely MA; Morris JG; Rail D; Reid WG; O'Sullivan DJ; Williamson PM; Genge S; Broe GA J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):324-8. PubMed ID: 2647907 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of bromocriptine and levodopa in Parkinson's disease. Duvoisin RC; Mendoza MM; Yahr MD Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618 [No Abstract] [Full Text] [Related]
10. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor]. LondoƵ R Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729 [TBL] [Abstract][Full Text] [Related]
11. Treatment of "on-off effect" with a dopa decarboxylase inhibitor. Sweet RD; McDowell FH; Wasterlain CG; Stern PH Arch Neurol; 1975 Aug; 32(8):560-3. PubMed ID: 1156214 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa]. Lombardo L; De la Garza R Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417 [TBL] [Abstract][Full Text] [Related]
14. [Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine]. Mizuno Y; Yoshida M; Obayashi T; Ueki A Rinsho Shinkeigaku; 1976 Jul; 16(7):511-9. PubMed ID: 986921 [No Abstract] [Full Text] [Related]
15. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients. Libman I; Gawel MJ; Riopelle RJ; Bouchard S Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120 [TBL] [Abstract][Full Text] [Related]
17. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease. Lieberman A; Goodgold A; Jonas S; Leibowitz M Neurology; 1975 Oct; 25(10):911-6. PubMed ID: 1101099 [TBL] [Abstract][Full Text] [Related]
18. Update on drug treatment of Parkinsonism. Winkelman AC Am Fam Physician; 1977 Jul; 16(1):118-20. PubMed ID: 18001 [No Abstract] [Full Text] [Related]
19. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa. Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700 [TBL] [Abstract][Full Text] [Related]
20. Response to Sinemet 25/100 in Parkinson's disease. Ulm G; Gerdes U; Lehmann K Adv Neurol; 1984; 40():541-7. PubMed ID: 6695634 [No Abstract] [Full Text] [Related] [Next] [New Search]